Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,708 | 1,461 | 0 | 0 | 172 |
| Gross Profit | 1,708 | 1,461 | N/A | N/A | 172 |
| Operating Expenses | 10,047 | 9,996 | 7,257 | 10,505 | 12,185 |
| Operating Income | -8,339 | -8,535 | -7,257 | -10,505 | -12,013 |
| Interest Expense | 88 | 346 | 725 | 877 | 943 |
| Other Income | 412 | -193 | 68 | 158 | 218 |
| Pre-tax Income | -8,015 | -9,074 | -7,914 | -11,224 | -12,738 |
| Net Income Continuous | -8,015 | -9,074 | -7,914 | -11,224 | -12,738 |
| Minority Interests | -982 | 1,231 | -2,502 | -4,532 | -5,474 |
| Net Income | $-7,033 | $-10,305 | $-5,412 | $-6,692 | $-7,264 |
| EPS Basic Total Ops | -0.04 | 0.07 | -0.12 | -0.18 | -0.22 |
| EPS Basic Continuous Ops | -0.04 | 0.24 | -0.17 | -0.31 | -0.38 |
| EPS Diluted Total Ops | -0.04 | 0.07 | -0.12 | -0.18 | -0.22 |
| EPS Diluted Continuous Ops | -0.04 | 0.24 | -0.17 | -0.31 | -0.38 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | -0.12 | -0.18 | -0.22 |
| EBITDA(a) | $-8,422 | $-8,436 | $-6,976 | $-10,215 | $-11,854 |